Literature DB >> 15211407

Feminizing genital reconstruction: experience with 52 cases of ambiguous genitalia.

A Al-Bassam1, A Gado.   

Abstract

AIM: The last decade witnessed the introduction of different modifications and even new techniques for feminizing genitoplasty. The claim was that the classical Hendren's procedure was associated with unsatisfactory results. At the King Khalid University Hospital, the Hendren's operation was the procedure of choice for feminizing genitoplasty. In this report, we describe our experience with a total of fifty-two cases of ambiguous genitalia. We understand that this comes in the midst of growing criticism of the Hendren's procedure.
MATERIALS AND METHODS: The medical records of 52 consecutive patients with ambiguous genitalia who underwent feminizing genital reconstruction were reviewed. Forty-five patients (86.5%) had congenital adrenal hyperplasia (CAH), 3 patients had testicular feminization syndrome, 2 patients had mixed gonadal dysgenesis, one patient had vaginal atresia with Kaufman's syndrome and one patient had isolated congenital clitoromegaly. Age at first presentation ranged between 1 day to 15 years. Feminizing genital reconstruction using Hendren's technique was carried out as a single stage procedure in 29 (55.81%) patients and as staged surgery in 23 (44.2%) patients. A total of 50 clitoral operations and 43 vaginoplasties were performed. Follow-up ranged from 6 months to 12 years (mean 3 and 1/2 years). The surgical results were analyzed and complications documented.
RESULTS: Reconstruction was completed in 47 (90.2%) patients. Thirty-six (78.2%) patients had a satisfactory genital appearance with normal looking clitoris. Seven patients required revision clitoroplasty. Thirty-six (83.7%) patients had a good size vagina appropriate for age. Seven patients (16.2%) had vaginal stenosis and two had revision vaginoplasty with good results. Postoperative complications included urethral fistula (one patient), meatal stenosis (one patient), and transient neurogenic bladder (one patient). The final cosmetic results were considered excellent in 40 (85.1%), fair in 4 patients, and poor in 3 patients.
CONCLUSION: The Hendren's techniques of flap vaginoplasty for low confluence and vaginal pull-through for high confluence offer satisfactory cosmetic and functional results. Long-term follow-up is necessary to ensure social and psychosexual adjustment.

Entities:  

Mesh:

Year:  2004        PMID: 15211407     DOI: 10.1055/s-2004-815869

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  4 in total

Review 1.  [Psychosexual aspects of intersex syndromes].

Authors:  H A G Bosinski
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

2.  Effects of feminizing reconstructive surgery on sexual function and genital sensitivity in patients with female pseudohermaphroditism versus healthy control.

Authors:  Gao Zhen; Gao Bowen; Xie Feng; Cheng Kaixiang; Dave Ho; Xiao Kaiyan
Journal:  Int Urol Nephrol       Date:  2016-05-12       Impact factor: 2.370

3.  Consensus in Guidelines for Evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team.

Authors:  Ganka Douglas; Marni E Axelrad; Mary L Brandt; Elizabeth Crabtree; Jennifer E Dietrich; Shannon French; Sheila Gunn; Lefkothea Karaviti; Monica E Lopez; Charles G Macias; Laurence B McCullough; Deepa Suresh; V Reid Sutton
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-17

4.  Preliminary report: Surgical outcomes following genitoplasty in children with moderate to severe genital atypia.

Authors:  K J Bernabé; N J Nokoff; D Galan; D Felsen; C E Aston; P Austin; L Baskin; Y-M Chan; E Y Cheng; D A Diamond; R Ellens; A Fried; S Greenfield; T Kolon; B Kropp; Y Lakshmanan; S Meyer; T Meyer; A M Delozier; L L Mullins; B Palmer; A Paradis; P Reddy; K J Scott Reyes; M Schulte; J M Swartz; E Yerkes; C Wolfe-Christensen; A B Wisniewski; D P Poppas
Journal:  J Pediatr Urol       Date:  2018-02-02       Impact factor: 1.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.